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Repair of mycotic aortic pseudoaneurysm with a
stent graft using transesophageal
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Chaikof, MD, PhD,a and Ross Milner, MD,a Atlanta, Ga
A 54-year-old man who underwent uneventful orthotopic heart transplantion 1 year previously had low-grade fever and
dyspnea. Imaging studies revealed an ascending aortic pseudoaneurysm (AAP), which was repaired with a 5-mm polyester
patch, with circulatory arrest and cardiopulmonary bypass. Intraoperative cultures of the AAP grew methicillin-resistant
Staphylococcus aureus, and the pseudoaneurysm recurred after 6 weeks despite intravenously administered antibiotic
therapy. A 28.5-mm 3.3-cm Gore Excluder aortic cuff was deployed in the ascending aorta through a left axillary artery
cutdown with use of combined transesophageal echocardiography and fluoroscopy. In addition, controlled hypotension
and asystole were established with administration of adenosine to facilitate precise device deployment. Postoperative
imaging with transesophageal echocardiography and magnetic resonance angiography revealed complete resolution of the
AAP, and the patient had done well at 7-month follow-up. Treatment of a mycotic aortic pseudoaneurysm with an
endoprosthesis in a patient without other treatment alternatives can be performed safely, with acceptable short-term
results. (J Vasc Surg 2004;40:567-70.)Clinicians familiar with commercially available stent
grafts have been required to deploy these devices in the
thoracic aorta as an off-label use no alternatives are avail-
able. We describe a case in which a mycotic ascending aortic
pseudoaneurysm (AAP) in a critically ill patient was treated
successfully with an aortic cuff.
CASE REPORT
A 51-year-old man with a history of insulin-dependent diabe-
tes mellitus received an orthotopic heart transplant in April 2002.
He did well with immunosuppressive therapy until July 2003,
when he manifested low-grade fever. Evaluation with computed
tomography (CT) revealed an AAP at the previous aortic suture
line, which was promptly repaired via a repeat sternotomy and
polyester patch. Circulatory arrest and full cardiopulmonary bypass
were used. Although initial blood cultures were negative, cultures
from the pseudoaneurysm eventually grew methicillin-resistant
Staphylococcus aureus, sensitive to linezolid, trimethoprim-sulfa-
methoxazole, and vancomycin. He was treated for 6 weeks with
intravenously administered vancomycin and rifampin. After the
course of antibiotic therapy the patient began to have chest pain,
fever, chills, and sweats. Repeat images revealed recurrence of the
AAP (Fig 1), and intravenous vancomycin and rifampin were
restarted and the patient was admitted to the hospital.
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doi:10.1016/j.jvs.2004.04.022At evaluation the patient appeared ill. He was febrile (temper-
ature, 101°F), and had tachycardia (sinus 105) and diaphoresis.
The examination was otherwise unremarkable. Laboratory studies
revealed leukocytosis (white blood cell count, 17,000/mm3),
anemia (hematocrit, 26%), and normal renal function (serum
creatinine concentration, 1.2 mg/dL). An echocardiogram docu-
mented no valvular abnormalities, and moderate depression of
right ventricular function. We concurred with the cardiothoracic
surgeons that the patient was too ill to survive repeat open AAP
repair.
Preoperative imaging with CT and magnetic resonance (MR)
angiography revealed that the AAP was located halfway between
the coronary ostia and the innominate artery. The total length of
this portion of the ascending aorta was approximately 5 cm. The
ascending aortic diameter measured on CT scans and MR images
was 28 mm.
In September 2003 an arch aortogram was obtained with the
OEC 9800 (GE Medical Systems) with a marker pigtail catheter to
confirm proximal and distal landing zones, aortic diameters, and
location of the pseudoaneurysm. Although angiography was un-
successful in enabling determination of the location of the lesion,
TEE proved essential. An anesthesiologist performed the study
with a Philips Sonos 5500 (Philips Medical Systems) with a 5-MHz
Omni 2 (Hewlett Packard) multiplane probe. The orientation of
the probe acquired primarily mid-esophageal long axis views of the
ascending aorta. With the TEE we were able to pinpoint the entry
site into the pseudoaneurysm (Fig 2), and measured the ascending
aortic diameter as 26 mm.
A left axillary artery cutdown was performed to provide access
for the device, and 80 U/kg of heparin was administered intrave-
nously. A 28.5-mm  3.3-cm Gore Excluder aortic cuff (W. L.
Gore & Associates) was introduced without a sheath into the
ascending aorta over a 300-cm Meier wire (Boston Scientific).
With real-time fluoroscopy and TEE, the cuff was deployed during567
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ment over the pseudoaneurysm entry site sealed it instantaneously.
When TEE demonstrated no flow in the sac, wires and catheters
were removed. The proximal axillary artery was discovered to be
frayed and dissected. After resecting to healthy tissue, the distal
artery could not be mobilized enough to perform primary end-to-
Fig 1. Computed tomography scan shows recurrent mycotic as-
cending aortic pseudoaneurysm measuring 8.2 cm in diameter 2
months after open repair with Dacron patch.
Fig 2. Transesophageal echocardiogram shows ascending aorta in
longitudinal axis. Color Doppler scan demonstrates flow into
ascending aortic pseudoaneurysm (AAP) in close proximity to
aortic valve (AV).end anastomosis, so the artery was repaired with a short segment
6-mm polyester interposition graft.
Postoperatively the patient did well, with a palpable left radial
pulse. Hematocrit and creatinine concentration remained stable.
Postoperative chest x-ray studies showed the aortic cuff in place.
The patient was discharged from the hospital 3 days after surgery,
with intravenous rifampin and vancomycin for an additional 6
weeks, followed by daily lifelong oral trimethoprim-sulfamethox-
azole. Follow-up TEE at 3 days and MR imaging at 2 months
revealed complete resolution of the pseudoaneurysm (Fig 3). At
7-month follow-up the patient had no recurrent infectious symp-
toms and demonstrated no subclinical recurrence on surveillance
MR angiograms (Fig 3).
DISCUSSION
Pseudoaneurysms complicate aortic grafting in 1% to
6% of cases. Repair of aortic pseudoaneurysms is associated
with high morbidity and mortality.1 There are several re-
ports of endovascular aneurysm repair (EVAR) in the treat-
ment of thoracic aortic pseudoaneurysms, mostly in the
trauma setting.2-4 The development of a mycotic aneurysm
after heart transplantation has also generated several case
reports.5,6 One case report describes a patient in whom
recurrent non-mycotic AAP developed after the Bentall
procedure, which was then treated successfully with a Tal-
ent aortic cuff (Medtronic AVE).7 Clearly there are enough
reports to validate the use of EVAR in treating thoracic
pseudoaneurysms, but none describe treating a mycotic
AAP with EVAR. In our patient it represented the only
viable treatment option.
We decided, in conjunction with our cardiac surgeons,
to follow up this patient closely, both clinically and radio-
logically, for signs of reinfection. No prophylactic operative
intervention is planned at this time, owing to his high risk.
We hope that lifelong antibiotic therapy and close surveil-
lance will avert pseudoaneurysm recurrence, but there are
no data to support this view.
We chose the Gore Excluder to treat this lesion for
several reasons. The first is that the 61-cm deployment
mechanism is slightly longer than that of the AneuRx
(Medtronic AVE), which measures 55 cm. The Zenith
(Cook Inc) was not yet FDA-approved at the time of this
case. Also, the Excluder is much more flexible, enabling
the device to track around the arch without difficulty.
Although the graft is intended for use through an 18F
sheath, we were unable to insert a sheath safely; therefore
we deployed the graft “bareback.” This was without
complication, but dragging an uncovered polytetrafluo-
roethylene graft across the origins of both carotid arter-
ies was not without some anxiety. Finally, the Excluder
has a slightly lower profile compared with the AneuRx,
which makes it easier to introduce through a relatively
diminutive axillary artery. One potential drawback of the
Excluder is the instantaneous deployment mechanism.
We find that experienced users can deploy this device
precisely, especially in the setting of controlled hypoten-
sion.
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preoperative images. The length of the device precluded
use of the femoral or iliac arteries, and the sheath size was
too large for a brachial or carotid approach. Although the
common carotid arteries have been described as a viable
access route, CT scans and MR angiograms revealed that
they were too small in this patient. The subclavian artery
and abdominal aorta would have been viable alternatives as
well, but the axillary artery was simply easier.
Helpful adjuncts in deploying thoracic endografts are
iatrogenic hypotension and TEE. We used adenosine to
temporarily arrest the heart, as described.8 Concerns about
using the cuff in the ascending aorta included covering the
coronary ostia, leading to acute myocardial infarction; cov-
ering the inominate artery origin, causing acute cerebrovas-
cular accident; and producing iatrogenic vascular injury
while introducing the device, necessitating emergent repeat
sternotomy. TEE is routinely used by cardiothoracic sur-
geons during open procedures, but is only sparingly de-
scribed in the endovascular literature. TEE is excellent for
visualizing the ascending or descending aorta; however,
there is a “blind spot” at the arch, due to the interposition
of the trachea.9-11 Since most endografts involve the prox-
imal descending aorta, it can be helpful, especially in pa-
tients with renal failure in whom administration of intrave-
nous contrast medium may be contraindicated. In our
patient excellent visualization of the AAP was obtained
with TEE that was not revealed at angiography. Similar
observations have been noted by others.12,13 TEE also can
enable real-time visualization of device deployment that
may not be obtainable with intravascular ultrasound scan-
ning.
Fig 3. Initial magnetic resonance angiogram (MRA)
7-month follow-up (right) reveal total resolution of ascUntil thoracic endograft components are commercially
available, clinicians can use components of abdominal en-
dografts to treat thoracic aortic disease when other options
are inadequate. This case report illustrates successful exclu-
sion of a mycotic AAP with an aortic cuff in a patient who
was not a candidate for open surgery. Longer follow-up is
needed to ascertain the success of this approach, because
the source of the infection has not been eradicated. TEE
and adenosine are helpful adjuncts when deploying stent
grafts in the thoracic aorta.
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